Copyright: ©Author(s) 2026.
World J Hepatol. Apr 27, 2026; 18(4): 114793
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.114793
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.114793
Table 4 Summary of the time-sensitive decisions in management of Clostridium difficile infection
| Patient phenotype (stage of illness) | Recommended action | Time frame |
| Symptomatic (suspected) | Multi-step diagnostics + start empiric therapy (fidaxomicin or vancomycin) | Within 24 hours |
| Severe/fulminant | High-dose oral vancomycin + IV metronidazole; consider rectal vancomycin | Immediately |
| First recurrence | Switch to fidaxomicin | As early as possible after recurrence |
| ≥ 2 recurrences | Add fecal microbiota transplantation promptly | As early as possible |
| Fulminant refractory to medical therapy | Surgical consultation (or ileostomy lavage) | Within hours/days of deterioration |
- Citation: Said EM, Soliman HH, Gabal HMR, Emara MH, Fouad Y, Elzahaby A, Anees M, Zaky S, Sakr MA. Time sensitive managements in hepato-gastroenterology. World J Hepatol 2026; 18(4): 114793
- URL: https://www.wjgnet.com/1948-5182/full/v18/i4/114793.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i4.114793